Literature DB >> 21845381

Does metformin work for everyone? A genome-wide association study for metformin response.

Jose C Florez1.   

Abstract

Entities:  

Year:  2011        PMID： 21845381     DOI： 10.1007/s11892-011-0220-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  17 in total

1.  Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.

Authors:  Cynthia R Ong; Lynda M Molyneaux; Maria I Constantino; Stephen M Twigg; Dennis K Yue
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

Review 2.  An energetic tale of AMPK-independent effects of metformin.

Authors:  Russell A Miller; Morris J Birnbaum
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

3.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

4.  Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

Authors:  A J Garber; T G Duncan; A M Goodman; D J Mills; J L Rohlf
Journal:  Am J Med       Date:  1997-12       Impact factor: 4.965

5.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Authors:  Yan Shu; Steven A Sheardown; Chaline Brown; Ryan P Owen; Shuzhong Zhang; Richard A Castro; Alexandra G Ianculescu; Lin Yue; Joan C Lo; Esteban G Burchard; Claire M Brett; Kathleen M Giacomini
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Authors:  Helena W Rodbard; Paul S Jellinger; Jaime A Davidson; Daniel Einhorn; Alan J Garber; George Grunberger; Yehuda Handelsman; Edward S Horton; Harold Lebovitz; Philip Levy; Etie S Moghissi; Stanley S Schwartz
Journal:  Endocr Pract       Date:  2009 Sep-Oct       Impact factor: 3.443

8.  Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-10-22       Impact factor: 10.122

9.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.

Authors:  Kathleen A Jablonski; Jarred B McAteer; Paul I W de Bakker; Paul W Franks; Toni I Pollin; Robert L Hanson; Richa Saxena; Sarah Fowler; Alan R Shuldiner; William C Knowler; David Altshuler; Jose C Florez
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461
View more
  7 in total

1.  Genetic variants of OCT1 influence glycemic response to metformin in Han Chinese patients with type-2 diabetes mellitus in Shanghai.

Authors:  Yong Zhou; Weiwei Ye; Yi Wang; Zhikui Jiang; Xiangying Meng; Qian Xiao; Qian Zhao; Jian Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes.

Authors:  Fizalah Kawoosa; Zafar A Shah; Shariq R Masoodi; Asif Amin; Roohi Rasool; Khalid M Fazili; Abid Hamid Dar; Asif Lone; Samir Ul Bashir
Journal:  BMC Endocr Disord       Date:  2022-05-26       Impact factor: 3.263

3.  Allele and genotype frequency of a genetic variant in ataxia telangiectasia mutated gene affecting glycemic response to metformin in South Indian population.

Authors:  Saranya Vilvanathan; Umamaheswaran Gurusamy; V Mukta; Ashok Kumar Das; Adithan Chandrasekaran
Journal:  Indian J Endocrinol Metab       Date:  2014-11

Review 4.  Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.

Authors:  Edith Pascale Mofo Mato; Magellan Guewo-Fokeng; M Faadiel Essop; Peter Mark Oroma Owira
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.

Authors:  Yulia A Nasykhova; Yury A Barbitoff; Ziravard N Tonyan; Maria M Danilova; Ivan A Nevzorov; Tatiana M Komandresova; Anastasiia A Mikhailova; Tatiana V Vasilieva; Olga B Glavnova; Maria I Yarmolinskaya; Evgenia I Sluchanko; Andrey S Glotov
Journal:  Genes (Basel)       Date:  2022-07-23       Impact factor: 4.141

Review 6.  Metformin as a geroprotector: experimental and clinical evidence.

Authors:  Veronika Piskovatska; Nadiya Stefanyshyn; Kenneth B Storey; Alexander M Vaiserman; Oleh Lushchak
Journal:  Biogerontology       Date:  2018-09-25       Impact factor: 4.277

Review 7.  Pharmacogenetics of Type 2 Diabetes-Progress and Prospects.

Authors:  Yulia A Nasykhova; Ziravard N Tonyan; Anastasiia A Mikhailova; Maria M Danilova; Andrey S Glotov
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.